Wound care |

Safetac® Technology: the innovation that changed wound care forever

With the invention of Safetac® Technology, Mölnlycke® revolutionised wound care, introducing a range of groundbreaking dressings specifically designed to minimise pain at dressing change. Discover how Safetac Technology can benefit you and your patients.

A photo of Thomas Fabo, the inventor of SafeTac®

What is Safetac Technology and how does it improve patient experience and outcomes?

As any clinician knows, patients can endure terrible pain when a dressing sticks to the wound or damages the skin. Likewise, a dressing that doesn’t protect the wound edges can cause skin breakdown which slows down healing and can prolong suffering for those with chronic wounds.

We know that clinicians want to prevent this suffering and offer their patients more effective treatment options. That’s where Safetac Technology comes in. 

Safetac Technology is the original game-changing contact layer. It is used across Mölnlycke’s advanced adhesive dressing ranges and facilitated the development of the first bordered silicone foam dressing. Safetac’s innovative design allows the dressing to mould softly to the skin and yet not stick to the moist wound1-5.  It will protect the wound edges to minimise risk of skin breakdown1,4,5,7 and make the dressing easy to remove without damaging the skin1-4.

It all adds up to a less painful experience for patients at dressing change1-6,9. The combination of less pain and less skin and wound damage is the reason that numerous randomised controlled trials associate dressings with Safetac Technology with faster wound healing2,3,4,9.

Which dressings feature Safetac Technology?

Since its launch at Mölnlycke, Safetac Technology has been a key technology behind our most successful dressings. The range of dressings with Safetac Technology has expanded over the years and there is now a foam dressing with Safetac Technology for almost every type of wound:

  • The Mepilex® range with soft conformable foam is suitable for many chronic (hard-to-heal) wounds. The newest member of this family, Mepilex Up, is designed especially for patients struggling with venous leg ulcers (VLUs) or similar exudating wounds.
  • Mepilex Border offered revolutionary exudate management and is now superseded by the next-generation, Mepilex Border Flex, with its increased ability to stay in place and conform.
  • Silver-impregnated dressings such as Mepilex Ag deliver gentle and effective burn care with an antimicrobial effect10.
  • Mepilex Border Sacrum and Mepilex Border Heel have extended the Safetac Technology influence beyond healing and into the prevention of pressure injuries.

Other advanced dressings also feature Safetac:

  • The Mepitel® range, the first wound contact layers to incorporate Safetac Technology, now includes Mepitel Film, a dressing proven to reduce radiotherapy-induced skin damage8.
  • Mepilex Border Post-Op, the advanced dressing for surgical incisions, was developed specifically to help reduce post operative complications and support patients’ early mobilisation1-6.

How well-trusted is Safetac Technology?

Since its launch, Safetac Technology has been used around the world to improve the wound care experience of hundreds of millions of patients.

Safetac Technology is trusted with good reason. At Mölnlycke, we are careful to support our products with robust evidence:

  • more than 450 peer-reviewed findings confirm Safetac’s performance advantages.
  • the evidence includes more than 30 randomised control studies.

What could Safetac Technology silicone dressings mean for your patients – and your budget?

We know clinicians want to reduce patient suffering with less painful treatment options that support faster healing and improved outcomes. We also understand the pressures to reduce the cost of care.

In addition to improving the patient experience at dressing change, Safetac Technology also:

  • protects new tissue and intact skin so wounds are undisturbed, supporting faster healing1-9.
  • seals wound margins to protect skin from leaks and maceration1,4,5,7.

By supporting faster healing, Safetac Technology can not only improve the patient experience, it can also reduce the cost of treatment2,6,9,10. 

What is the story behind the development of Safetac Technology?

Safetac was invented by a young product designer at Mölnlycke called Tomas Fabo at a time when advanced wound care technology was in its infancy. Tomas had seen at first hand the pain patients can experience during dressing changes and became driven by the need to prevent this suffering. 

He began experimenting – even working at night in his own kitchen. Eventually he developed a type of silicone that was to become the key component of our early Mepitel range launched in 1989. Its promise was simple: it wouldn’t stick to the wound and it wouldn’t damage the skin and therefore, be less painful to remove.

The rest is history. Tomas achieved his aims and Safetac Technology continues to be at the heart of our advanced dressing ranges, including our most recent innovation, Mepilex® Up.

 

A flowchart showing the SafeTac® timeline.

How has Safetac changed the way we think about wound care?

Since the launch of Mepitel® in 1989, Mölnlycke has sold well over 4 billion dressings with Safetac Technology, helping millions of people experience less painful healing and preventing hundreds of thousands of pressure Injuries.

Thanks to Safetac, wound care is now gentler, more effective, and more innovative than ever before.

 

    1. Beele H. et al. A prospective randomized controlled clinical investigation comparing two post-operative wound dressings used after elective hip and knee replacement; Mepilex® Border Post-Op versus Aquacel® surgical. International Journal of Orthopaedic and Trauma Nursing, 2020.
    2. Silverstein P. et al. An open, parallel, randomized, comparative, multicenter study to evaluate the cost-effectiveness, performance, tolerance, and safety of a silver-containing soft silicone foam. Journal of Burn Care and Research, 2011.
    3. Gee Kee E.L. et al. Randomized controlled trial of three burns dressings for partial thickness burns in children. Burns, 2014.
    4. David F. et al. A randomised, controlled, non-inferiority trial comparing the performance of a soft silicone-coated wound contact layer (Mepitel One) with a lipidocolloid wound contact layer (UrgoTul) in the treatment of acute wounds. International Wound Journal, 2017.
    5. Patton M.L. et al.. An open, prospective, randomized pilot investigation evaluating pain with the use of a soft silicone wound contact layer vs bridal veil and staples on split thickness skin grafts as a primary dressing. Journal of burn care & research, 2013
    6. Bredow J. et al. Evaluation of Absorbent Versus Conventional Wound Dressing. A Randomized Controlled Study in Orthopedic Surgery. Deutsche Arzteblatt International, 2018.
    7. Meaume S. et al. A study to compare a new self-adherent soft silicone dressing with a self-adherent polymer dressing in stage II pressure ulcers. Ostomy Wound Management, 2003.
    8. Herst P. et al. Prophylactic use of Mepitel Film prevents radiation-induced moist desquamation in an intra-patient randomised controlled clinical trial of 78 breast cancer patients. Radiotherapy and Oncology, 2014.
    9. Gotschall C.S. et al. Prospective, randomized study of the efficacy of Mepitel on children with partial-thickness scalds. Journal of Burn Care & Rehabilitation, 1998.
    10. Gee Kee E. L. et al. Cost-effectiveness of silver dressings for paediatric partial thickness burns: An economic evaluation from a randomized controlled trial. Burns, 2017.
    11. Chadwick P, Taherinejad F, Hamberg K, Waring M. Clinical and scientific data on a silver-containing soft-silicone foam dressing: an overview. Journal of Wound Care 2009;18(11):483-491.

Select country

Get knowledge, learn about our products, get support and more.

Australia

No markets

Find jobs, our financial reports and more.

Mölnlycke corporate